Oprozomib, pomalidomide, and dexamethasone in patients with relapsed and/or refractory multiple myeloma

出版年份 2019 全文链接

标题

作者

关键词

Proteasome inhibitor, Clinical Trials, Oncology, Pharmacokinetics, Therapy

出版物

Volume -, Issue -, Pages -

出版商

Elsevier BV

发表日期

2019-05-29

DOI

10.1016/j.clml.2019.05.017

联系作者

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation